Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 January 2021 | Story Lacea Loader
Ivermectin

FARMOVS, a wholly owned clinical research company of the University of the Free State (UFS), together with several medical and scientific experts at the university, is currently in the process of preparing a clinical trial protocol to determine the efficacy of Ivermectin for COVID-19 in a randomised, controlled study according to the requirements of the legal professions, in order to submit it for approval to the relevant national regulatory authority.

FARMOVS is a South African specialty full-service clinical research organisation conducting ICH-GCP-compliant Phase I to IV clinical trials. FARMOVS’ competitive advantage is its wealth of bioequivalence and Phase I experience and expertise, patient recruitment success, and a clinical research facility with the only onsite ISO (International Organization for Standardization) and GLP (Good Laboratory Practice) certified bioanalytical laboratory on the African continent.

By participating in the preparation of the clinical trial protocol, FARMOVS and the UFS remain supportive of and committed to contributing to the development of treatments and treatment strategies to battle the COVID-19 pandemic. Should the clinical trial protocol be approved by the relevant national regulatory authority, the UFS will be the first university in South Africa to attempt such a study.

The university management is aware of a WhatsApp voice clip being circulated, in which reference is made to a particular meeting, and mention is made of the role the institution is playing in establishing the efficacy of Ivermectin for COVID-19. The voice clip is premature and was shared with a small group, from where it went viral. The voice clip is also not factual – specifically regarding the university and its alleged opinion pertaining to the usage and need for scientific investigation into the matter.  

The UFS is committed to rigorous science and evidence-based research, and both FARMOVS and the university fully support the published opinions and guidelines of the South African Health Products Regulatory Authority (SAHPRA) and the scientific advisory boards established by the scientific community, as well as the stance of the South African government on Ivermectin for COVID-19.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

UFS Leads ASGISA Training
2006-07-17

The University of the Free State (UFS) has been appointed as training service provider for the national programme for the creation of small enterprises and jobs in the second economy. This major national programme has a target of creating one million jobs for poor people in rural and peri-urban areas, which forms part of the government’s Accelerated and Shared Growth Initiative (ASGI-SA). The main method of training will be through the formation of self-help groups and cooperatives with access to business support and micro finance.

Prof Frans Swanepoel, Director of the UFS Research Development Directorate, acts as advisor to the national programme leader, Ms Vuyo Mahlati.  Dr Aldo Stroebel, senior researcher at the UFS Research Development Directorate, has been appointed as programme co-ordinator, based at the UFS. Prof Basie Wessels, Director of the  Mangaung-University Community Partnership Programme (MUCPP), has been appointed as the training co-ordinator and Ms Sazini Ndlovu as programme assistant based at the Independent Development Trust (IDT) in Pretoria.

Dr Stroebel has co-ordinated the development of a training programme, while Prof Wessels presented the “training-of-trainers” course at the MUCPP last month. This course was attended by trainers and trainer-assistants, identified and selected by the local economic development groups in each of the nine provinces, as well as trainers from Hand-in-Hand (HiH), an Indian non-governmental organisation acting as counterpart to the UFS in the provision of training.

Pictured here at the training session at the MUCPP were from the left: Prof Frans Swanepoel, Mr Gnanavel Mookkan (HiH), Dr Rendani Ralinala (IDT), Ms Sazini Ndlovu (national programme assistant), Mr Chinnaiah Meenakshisundaram (HiH), Dr Aldo Stroebel, Ms Vuyo Mahlati (national programme leader) and Prof Basie Wessels.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept